M&A Deal Summary

Unison Capital Acquires Kyowa Pharmaceutical Industry

On November 11, 2019, private equity firm Unison Capital acquired life science company Kyowa Pharmaceutical Industry from Lupin

Acquisition Highlights
  • This is Unison Capital’s 3rd transaction in the Life Science sector.
  • This is Unison Capital’s 29th transaction in Japan.

M&A Deal Summary

Date 2019-11-11
Target Kyowa Pharmaceutical Industry
Sector Life Science
Buyer(s) Unison Capital
Sellers(s) Lupin
Deal Type Secondary Buyout

Target

Kyowa Pharmaceutical Industry

Osaka, Japan
website
Kyowa Pharmaceutical Industry Co., Ltd. is a generic pharmaceutical company and is the domestic provider in the Central Nervous System (CNS) therapeutic area. Kyowa was founded in 1954 and is based in Osaka, Japan.

Search 191,543 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Unison Capital

Tokyo, Japan

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1998
PE ASSETS 3.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Unison Capital is a private equity investment firm focused on control investments in mid-cap companies operating in Japan, Korea, and Singapore. Target transaction situations include growth support, business successions, corporate carve-outs, buyouts, and restructurings. Unison is a generalist investor, however the Firm has a preference for opportunities in the retail, niche manufacturing, and healthcare sectors. Unison Capital was formed in 1998 and has offices in Tokyo, Seoul, and Singapore.


DEAL STATS #
Overall 33 of 38
Sector (Life Science) 3 of 3
Type (Secondary Buyout) 5 of 5
Country (Japan) 29 of 32
Year (2019) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-21 Pyuru

Itoshima, Japan

Pyuru Co., Ltd. is a provider in the manufacturer and sale of hair care and cosmetic products, with a focus on naturally-derived and additive-free ingredients. Pyuru “Rishiri Hair Color” brand has solidified a No.1 position within the gray hair color treatment market in Japan. Pyuru was founded in 1998 and is based in Itoshima, Japan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-01 Medit

Seoul, South Korea

Medit Corp. is a provider of 3D measurement and CAD/CAM solutions. Medit specializes in model and impression 3D scanners for dental clinics and labs, including intraoral scanners, based on our own patented state-of-the-art technology. Medit was founded in 2000 and is based in Seoul, South Korea.

Buy -

Seller(S) 1

SELLER

Lupin

Mumbai, India

website


Category Company
Founded 1968
Sector Life Science
Employees19,789
Revenue 161.9B INR (2022)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, India.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Secondary Buyout) 1 of 1
Country (Japan) 1 of 1
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-11 Symbiomix Therapeutics

Newark, New Jersey, United States

Symbiomix Therapeutics is a privately held company focused on bringing innovative therapies to market for gynecologic infections that can have serious health consequences. Symbiomix Therapeutics was founded in 2012 and is based in Newark, New Jersey.

Buy $150M